1. European Medicines Agency: EMA/464905/2010. Evaluation of Medicines for Human Use. CHMP Assessment report. Daxas, (2010) 46. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001179/WC500095213.pdf (acessado 1 de maio de 2016).
2. Roflumilast in the treatment of chronic obstructive pulmonary disease, Hot Top;Izquierdo;Respir. Med.,2010
3. Stability Testing of New Drug and Products Q1A(R2);ICH,2003
4. Rapid liquid chromatographic method for the determination of roflumilast in the presence of degradation products;Barhate;Indian J Pharm Sci.,2010
5. Analytical method development and validation of RP-HPLC for estimation of roflumilast in bulk drug and tablet dosage form;Ladani;Int. J. Pharm. Res. Sch.,2012